Concepedia
Statistics
Publications
15
Citations
6.2K
H-Index
Active since
1992
Affiliations
University of Michigan(Current)
Ottawa Regional Cancer Foundation
DuPont (United States)
Wilmington University
Rotterdam University of Applied Sciences
B.K. Dallaire is an author at University of Michigan specializing in medicine, oncology, and chemotherapy.
Publications per year
1992–2011
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
Peter McLaughlin, A.J. Grillo-López, Brian K. Link et al. · Journal of Clinical Oncology · 1998 · 2.8K citations
Pharmacy, Hematology, Immunology +17
IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma
David G. Maloney, Antonio J Grillo-López, Christine A. White et al. · Blood · 1997 · 1.7K citations
Medicine, Hematology, Oncology +14
Treatment of Patients With Low-Grade B-Cell Lymphoma With the Combination of Chimeric Anti-CD20 Monoclonal Antibody and CHOP Chemotherapy
M. S. Czuczman, A.J. Grillo-López, Christine A. White et al. · Journal of Clinical Oncology · 1999 · 856 citations
Medicine, Hematology, Oncology +15
Overview of the clinical development of rituximab: first monoclonal antibody approved for the treatment of lymphoma.
A.J. Grillo-López, Christine A. White, C. Varns et al. · PubMed · 1999 · 294 citations
Pharmacy, Immunology, Oncology +14
David G. Maloney, Antonio J Grillo-López, Christine A. White et al. · Blood · 1997 · 156 citations · Full text
1–5 of 15